Key facts
- Kilele Health’s last known valuation is $17.0M (Jan 2026).
- It has raised $260K across 1 recorded rounds; the latest was Seed Round ($265K) in Sep 2025.
- Notable investors include US National Science Foundation, 1819 Innovation Hub, JumpStart, Ohio State Early Investor Network, Ohio Third Frontier Commission — 6 tracked in total.
- 2 investment vehicles were formed to buy Kilele Health shares in the last 12 months, per SEC Form D filings.
- Kilele Health has filed 1 Form D with the SEC, most recently Oct 2025 ($265K sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Kilele Health
Funding rounds
1 roundsSecondary demand: investment vehicles
from SEC Form D filingsIn the last 12 months, 2 investment vehicles were formed to buy Kilele Health shares across 2 sponsors. Most recent filing Apr 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.
About Kilele Health
Developer of a remote patient monitoring device designed for chronic disease management. The company offers aptamer biosensors that can monitor for 2 weeks in the body, embodied in a form factor and user interface that mimics proven continuous glucose monitoring (CGM) wearable, enabling patients to measure important disease parameters in real-time and improve the management of chronic diseases.
- Sector
- Healthcare
- HQ
- Oakwood, OH, United States
- Founded
- 2021
- Employees
- 7
- Website
- kilelehealth.com/
- Ownership
- Privately Held (backing)
Kilele Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kilele Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kilele Health in its N-PORT filings yet. We sweep new filings monthly.